|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Tukysa Makes Waves as Firstline Maintenance in HER2+ Breast Cancer
2
Just Diagnosed with Cancer? Read This Before You Google Anything
3
The Current Treatment Landscape in Multiple Myeloma
4
Tukysa May Be ‘Patient Friendly’ Frontline Maintenance Option in HER2+ Breast Cancer
5